pearl bloodstock limited Company Information
Company Number
07165856
Next Accounts
Sep 2025
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Shareholders
pearling investments ltd
Group Structure
View All
Contact
Registered Address
lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Website
qatarracingltd.compearl bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of PEARL BLOODSTOCK LIMITED at £1.1m based on a Turnover of £2.3m and 0.48x industry multiple (adjusted for size and gross margin).
pearl bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of PEARL BLOODSTOCK LIMITED at £0 based on an EBITDA of £-1.9k and a 3.55x industry multiple (adjusted for size and gross margin).
pearl bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of PEARL BLOODSTOCK LIMITED at £0 based on Net Assets of £-3.1m and 2.2x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pearl Bloodstock Limited Overview
Pearl Bloodstock Limited is a live company located in newmarket, CB8 9AE with a Companies House number of 07165856. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in February 2010, it's largest shareholder is pearling investments ltd with a 100% stake. Pearl Bloodstock Limited is a established, small sized company, Pomanda has estimated its turnover at £2.3m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pearl Bloodstock Limited Health Check
Pomanda's financial health check has awarded Pearl Bloodstock Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £2.3m, make it smaller than the average company (£2.9m)
- Pearl Bloodstock Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -36%, show it is growing at a slower rate (7%)
- Pearl Bloodstock Limited
7% - Industry AVG
Production
with a gross margin of 24.2%, this company has a higher cost of product (45%)
- Pearl Bloodstock Limited
45% - Industry AVG
Profitability
an operating margin of -0.1% make it less profitable than the average company (5.7%)
- Pearl Bloodstock Limited
5.7% - Industry AVG
Employees
with 10 employees, this is below the industry average (23)
- Pearl Bloodstock Limited
23 - Industry AVG
Pay Structure
on an average salary of £53k, the company has an equivalent pay structure (£53k)
- Pearl Bloodstock Limited
£53k - Industry AVG
Efficiency
resulting in sales per employee of £229.5k, this is more efficient (£124.5k)
- Pearl Bloodstock Limited
£124.5k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (56 days)
- Pearl Bloodstock Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 653 days, this is slower than average (31 days)
- Pearl Bloodstock Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pearl Bloodstock Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pearl Bloodstock Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 415615.7%, this is a higher level of debt than the average (53%)
415615.7% - Pearl Bloodstock Limited
53% - Industry AVG
PEARL BLOODSTOCK LIMITED financials
Pearl Bloodstock Limited's latest turnover from December 2023 is estimated at £2.3 million and the company has net assets of -£3.1 million. According to their latest financial statements, we estimate that Pearl Bloodstock Limited has 10 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 742,680 | 2,589,041 | 4,114,269 | 5,906,606 | 1,831,180 | |||||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
Cost Of Sales | 1,168,510 | 2,481,677 | 5,706,317 | 5,043,177 | 1,694,628 | |||||||||
Gross Profit | -425,830 | 107,364 | -1,592,048 | 863,429 | 136,552 | |||||||||
Admin Expenses | 135,121 | 185,512 | 269,308 | 163,044 | 58,697 | |||||||||
Operating Profit | -560,951 | -78,148 | -1,861,356 | 700,385 | 77,855 | |||||||||
Interest Payable | 0 | 0 | 5,352 | 2,550 | 412 | |||||||||
Interest Receivable | 0 | 0 | 0 | 0 | 0 | |||||||||
Pre-Tax Profit | -560,951 | -78,148 | -1,866,708 | 697,835 | 77,443 | |||||||||
Tax | 0 | 0 | 0 | 0 | 0 | |||||||||
Profit After Tax | -560,951 | -78,148 | -1,866,708 | 697,835 | 77,443 | |||||||||
Dividends Paid | 0 | 0 | 0 | 0 | 0 | |||||||||
Retained Profit | -560,951 | -78,148 | -1,866,708 | 697,835 | 77,443 | |||||||||
Employee Costs | 0 | 0 | 0 | |||||||||||
Number Of Employees | 3 | 2 | 2 | |||||||||||
EBITDA* | -555,163 | -78,148 | -1,861,356 | 700,385 | 77,855 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,642,874 | 3,648,662 | 3,463,344 | 3,436,763 | 3,348,775 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,642,874 | 3,648,662 | 3,463,344 | 3,436,763 | 3,348,775 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 2,035,016 | 1,489,767 | 1,722,923 | 2,542,450 | 1,443,900 | 4,830,646 | 5,502,984 | 3,680,000 |
Trade Debtors | 750 | 1,549 | 220 | 0 | 3,898,153 | 3,927,132 | 2,123,147 | 9,718 | 424,791 | 2,555,324 | 569,086 | 29,271 | 670,608 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,178,491 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,087,857 | 1,433,399 | 0 | 0 | 443,518 | 538,548 | 404,884 |
Cash | 0 | 0 | 3,118 | 32,293 | 20,774 | 11,041 | 218,494 | 465,211 | 153,509 | 225,671 | 595,631 | 699,806 | 2,094,163 | 689,923 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 750 | 1,549 | 3,338 | 32,293 | 3,918,927 | 3,938,173 | 4,376,657 | 3,052,553 | 3,734,622 | 5,323,445 | 2,608,617 | 7,181,732 | 8,806,303 | 4,774,807 |
total assets | 750 | 1,549 | 3,338 | 32,293 | 3,918,927 | 3,938,173 | 4,376,657 | 6,695,427 | 7,383,284 | 8,786,789 | 6,045,380 | 10,530,507 | 8,806,303 | 4,774,807 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 3,117,118 | 3,116,018 | 3,115,254 | 3,139,520 | 7,017,350 | 7,017,350 | 7,500,960 | 109,815 | 679,564 | 1,128,416 | 400,266 | 1,480,480 | 808,084 | 78,222 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,134,207 | 7,111,432 | 4,618,142 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,521,188 | 7,017,350 | 7,954,850 | 6,031,356 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60,995 | 0 | 0 | 6,250 | 110,509 | 0 |
total current liabilities | 3,117,118 | 3,116,018 | 3,115,254 | 3,139,520 | 7,017,350 | 7,017,350 | 7,500,960 | 7,631,003 | 7,757,909 | 9,083,266 | 6,431,622 | 11,620,937 | 8,030,025 | 4,696,364 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 3,117,118 | 3,116,018 | 3,115,254 | 3,139,520 | 7,017,350 | 7,017,350 | 7,500,960 | 7,631,003 | 7,757,909 | 9,083,266 | 6,431,622 | 11,620,937 | 8,030,025 | 4,696,364 |
net assets | -3,116,368 | -3,114,469 | -3,111,916 | -3,107,227 | -3,098,423 | -3,079,177 | -3,124,303 | -935,576 | -374,625 | -296,477 | -386,242 | -1,090,430 | 776,278 | 78,443 |
total shareholders funds | -3,116,368 | -3,114,469 | -3,111,916 | -3,107,227 | -3,098,423 | -3,079,177 | -3,124,303 | -935,576 | -374,625 | -296,477 | -386,242 | -1,090,430 | 776,278 | 78,443 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | -560,951 | -78,148 | -1,861,356 | 700,385 | 77,855 | |||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 21,223 | 5,788 | 0 | 0 | 0 | 0 | ||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | 0 | 0 | 0 | |||||||||
Stock | 0 | 0 | 0 | 0 | 0 | -2,035,016 | 545,249 | -233,156 | -819,527 | 1,098,550 | -3,386,746 | -672,338 | 1,822,984 | 3,680,000 |
Debtors | -799 | 1,329 | 220 | -3,898,153 | -28,979 | 1,803,985 | 1,025,572 | -760,615 | -697,134 | 1,986,238 | -1,082,194 | 442,124 | 804,272 | 404,884 |
Creditors | 1,100 | 764 | -24,266 | -3,877,830 | 0 | -483,610 | 7,391,145 | -569,749 | -448,852 | 728,150 | -1,080,214 | 672,396 | 729,862 | 78,222 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60,995 | 60,995 | 0 | -6,250 | -104,259 | 110,509 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -192,136 | -1,063,005 | -1,086,500 | -3,928,807 | ||||||||||
Investing Activities | ||||||||||||||
capital expenditure | -3,348,775 | 0 | 0 | |||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | -3,348,775 | 0 | 0 | |||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10,134,207 | 3,022,775 | 2,493,290 | 4,618,142 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | -7,521,188 | 503,838 | -937,500 | 1,923,494 | 6,031,356 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 0 | 0 | -5,352 | -2,550 | -412 | |||||||||
cash flow from financing | 503,838 | -937,500 | 3,017,423 | 2,490,740 | 4,618,730 | |||||||||
cash and cash equivalents | ||||||||||||||
cash | 0 | -3,118 | -29,175 | 11,519 | 9,733 | -207,453 | -246,717 | 311,702 | -72,162 | -369,960 | -104,175 | -1,394,357 | 1,404,240 | 689,923 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | -3,118 | -29,175 | 11,519 | 9,733 | -207,453 | -246,717 | 311,702 | -72,162 | -369,960 | -104,175 | -1,394,357 | 1,404,240 | 689,923 |
pearl bloodstock limited Credit Report and Business Information
Pearl Bloodstock Limited Competitor Analysis
Perform a competitor analysis for pearl bloodstock limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CB8 area or any other competitors across 12 key performance metrics.
pearl bloodstock limited Ownership
PEARL BLOODSTOCK LIMITED group structure
Pearl Bloodstock Limited has no subsidiary companies.
Ultimate parent company
PEARLING INVESTMENTS LTD
#0073394
1 parent
PEARL BLOODSTOCK LIMITED
07165856
pearl bloodstock limited directors
Pearl Bloodstock Limited currently has 2 directors. The longest serving directors include Mr David Redvers (Feb 2010) and Sheikh Fahad Al Thani (Feb 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr David Redvers | 54 years | Feb 2010 | - | Director | |
Sheikh Fahad Al Thani | England | 35 years | Feb 2012 | - | Director |
P&L
December 2023turnover
2.3m
-5%
operating profit
-1.9k
0%
gross margin
24.3%
+2.72%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-3.1m
0%
total assets
750
-0.52%
cash
0
0%
net assets
Total assets minus all liabilities
pearl bloodstock limited company details
company number
07165856
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
February 2010
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
December 2023
previous names
pearling bloodstock ltd (May 2010)
accountant
-
auditor
-
address
lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Bank
WEATHERYS BANK LIMITED
Legal Advisor
-
pearl bloodstock limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pearl bloodstock limited.
pearl bloodstock limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PEARL BLOODSTOCK LIMITED. This can take several minutes, an email will notify you when this has completed.
pearl bloodstock limited Companies House Filings - See Documents
date | description | view/download |
---|